Hancom Lifecare Reports Expanded Operating Loss in Q1 2026: Revenue Down, Inventory Surges

Consolidated Q1 2026 revenue fell 9.9% YoY to KRW 5.99B from KRW 6.64B
Operating loss of KRW 3.81B (prior-year quarter operating loss not disclosed)
Net loss improved to KRW 2.23B from KRW 2.81B in Q1 2025
Inventory surged 75% to KRW 56.45B from KRW 32.24B at year-end 2025 (inventory turnover decline)
Operating cash flow remained negative at KRW (14.94)B
Cash and equivalents dropped 30% to KRW 35.96B from KRW 51.34B
Major orders: K5 gas mask 9th batch KRW 18.58B, ground laser target designator KRW 86.56B
R&D spending increased to KRW 0.5B (8.06% of sales)
Three ongoing lawsuits (patent infringement, damages, bidding restriction) – outcome uncertain
Credit rating maintained at A0 (Korea Rating Data), no capital impairment